세계의 정맥내 수액요법 시장 규모, 점유율, 동향 분석 : 서비스별, 구성요소별, 프로바이더 종류별, 지역별, 부문별 예측(2025-2033년)

Intravenous Hydration Therapy Market Summary

The global intravenous hydration therapy market size was estimated at USD 2.64 billion in 2024 and is projected to reach USD 5.66 billion by 2033, growing at a CAGR of 9.0% from 2025 to 2033. This growth is attributed to the rising prevalence of chronic diseases, the growing popularity of wellness and beauty treatments, and the increasing availability of intravenous (IV) hydration therapy clinics, as well as the ease of use associated with this therapy.

The increasing demand for IV hydration therapy is driven by the shift toward convenient, personalized wellness options beyond traditional clinical care. For instance, in August 2025, AquaPulse IV introduced mobile IV therapy services in Fredericksburg, Virginia. The service provides customized hydration and vitamin infusions directly to clients' homes, workplaces, or events, administered by licensed medical professionals. This development shows how IV therapy is becoming part of a lifestyle and preventive health approach, offering people quick recovery, energy boosts, and immune support in environments that fit their daily routines. These on-demand models highlight the rising focus on accessibility and patient-centered care in wellness services.

Growing consumer interest in preventive wellness, recovery solutions, and personalized care models is driving the expansion of the IV hydration therapy market. Beyond traditional hydration and nutrient replacement, providers offer specialized services supporting long-term health goals. For instance, in May 2025, Hydration Room introduced the NAD+ IV Membership with tiered dosing options to enhance brain health, energy, and longevity. By providing monthly access to clinically supervised NAD+ therapy in flexible doses, the program exemplifies a wider trend toward subscription-based, customized care that prioritizes consistency, convenience, and proactive health management. These innovations, along with the growth of mobile IV services and tech-enabled delivery models, are turning IV hydration therapy into a mainstream wellness option that serves both acute recovery and ongoing health optimization.

Furthermore, IV hydration therapy has gained immense popularity in the cosmetic industry, owing to the skincare benefits offered by the procedure. Extensive research found that the therapy helps in providing beauty treatment by hydrating the skin, further enhancing the appearance of an individual. IV hydration therapy is believed to enhance the normal production of elastin and collagen, which are responsible for maintaining youthful and healthy-looking skin. This can help to reduce the appearance of wrinkles and fine lines over time.

Global Intravenous (IV) Hydration Therapy Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global intravenous (IV) hydration therapymarket report based on service, component, provider type, end use and regions.

• Service Outlook (Revenue, USD Million, 2021 - 2033)
• Immune Boosters
• Energy Boosters
• Hydration
• Beauty/ Aesthetics
• Detoxification
• Longevity/ Antiaging
• Performance/ Athletics
• Migraine & Pain Relief
• Stress/Sleep/Mood Support
• Flu/Stomach
• Others
• Component Outlook (Revenue, USD Million, 2021 - 2033)
• Medicated
• Non-medicated
• Provider Type Outlook (Revenue, USD Million, 2021 - 2033)
• Mobile Providers
• Physical Providers
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals & Clinics
• Wellness Centers and Spas
• Home Healthcare
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service
  • 1.2.2. Component
  • 1.2.3. Provider Type
  • 1.2.4. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing demand for quick rehydration and recovery solutions
    • 3.2.1.2. Increasing adoption of wellness and preventive healthcare trends
    • 3.2.1.3. Rising popularity of IV nutrient therapy for beauty, skin rejuvenation, and anti-aging benefits
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Risk of side effects, including infections, vein inflammation, or allergic reactions
    • 3.2.2.2. High cost of treatments compared to oral supplements and conventional care
    • 3.2.2.3. Limited insurance coverage, making therapies less accessible to many patients
  • 3.2.3. Industry Opportunity Analysis
  • 3.2.4. Industry Challenge Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal Landscape

Chapter 4. Intravenous (IV) Hydration Therapy Market: Service Estimates & Trend Analysis

• 4.1. Service Segment Dashboard
• 4.2. Service Market Share Movement Analysis, 2024 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Service, 2021 to 2033 (USD Million)
• 4.4. Immune Boosters
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Energy Boosters
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Hydration
  • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Beauty/ Aesthetics
  • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Detoxification
  • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Longevity/ Antiaging
  • 4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Performance/ Athletics
  • 4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.11. Migraine & Pain Relief
  • 4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.12. Stress/Sleep/Mood Support
  • 4.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.13. Flu/Stomach
  • 4.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.14. Others
  • 4.14.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Intravenous (IV) Hydration Therapy Market: Component Estimates & Trend Analysis

• 5.1. Component Segment Dashboard
• 5.2. Component Market Share Movement Analysis, 2024 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
• 5.4. Medicated
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Non-Medicated
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Intravenous (IV) Hydration Therapy Market: Provider Type Estimates & Trend Analysis

• 6.1. Provider Type Dashboard
• 6.2. Provider Type Market Share Movement Analysis, 2024 & 2033
• 6.3. Market Size & Forecasts and Trend Analysis, by Provider Type, 2021 to 2033 (USD Million)
• 6.4. Mobile Providers
  • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Physical Providers
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Intravenous (IV) Hydration Therapy Market: End Use Estimates & Trend Analysis

• 7.1. End use Segment Dashboard
• 7.2. End use Market Share Movement Analysis, 2024 & 2033
• 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Healthcare Providers
  • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Hospitals & Clinics
  • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Wellness Centers & Spas
  • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Home Healthcare
  • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Others
  • 7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Intravenous (IV) Hydration Therapy Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Dashboard
• 8.2. Regional Market: Key Takeaways
• 8.3. North America
  • 8.3.1. North America Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key country dynamic
    • 8.3.2.2. Regulatory framework
    • 8.3.2.3. Competitive insights
    • 8.3.2.4. U.S. Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key country dynamic
    • 8.3.3.2. Regulatory framework
    • 8.3.3.3. Competitive insights
    • 8.3.3.4. Canada Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key country dynamic
    • 8.3.4.2. Regulatory framework
    • 8.3.4.3. Competitive insights
    • 8.3.4.4. Mexico Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamic
    • 8.4.2.2. Regulatory framework
    • 8.4.2.3. Competitive insights
    • 8.4.2.4. Germany Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. UK
    • 8.4.3.1. Key country dynamic
    • 8.4.3.2. Regulatory framework
    • 8.4.3.3. Competitive insights
    • 8.4.3.4. UK Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key country dynamic
    • 8.4.4.2. Regulatory framework
    • 8.4.4.3. Competitive insights
    • 8.4.4.4. France Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key country dynamic
    • 8.4.5.2. Regulatory framework
    • 8.4.5.3. Competitive insights
    • 8.4.5.4. Italy Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key country dynamic
    • 8.4.6.2. Regulatory framework
    • 8.4.6.3. Competitive insights
    • 8.4.6.4. Spain Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key country dynamic
    • 8.4.7.2. Regulatory framework
    • 8.4.7.3. Competitive insights
    • 8.4.7.4. Denmark Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key country dynamic
    • 8.4.8.2. Regulatory framework
    • 8.4.8.3. Competitive insights
    • 8.4.8.4. Sweden Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key country dynamic
    • 8.4.9.2. Regulatory framework
    • 8.4.9.3. Competitive insights
    • 8.4.9.4. Norway Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key country dynamic
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive insights
    • 8.5.2.4. Japan Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key country dynamic
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive insights
    • 8.5.3.4. China Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key country dynamic
    • 8.5.4.2. Regulatory framework
    • 8.5.4.3. Competitive insights
    • 8.5.4.4. India Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamic
    • 8.5.5.2. Regulatory framework
    • 8.5.5.3. Competitive insights
    • 8.5.5.4. South Korea Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key country dynamic
    • 8.5.6.2. Regulatory framework
    • 8.5.6.3. Competitive insights
    • 8.5.6.4. Australia Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key country dynamic
    • 8.5.7.2. Regulatory framework
    • 8.5.7.3. Competitive insights
    • 8.5.7.4. Thailand Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Intravenous (IV) Hydration Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key country dynamic
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive insights
    • 8.6.2.4. Brazil Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key country dynamic
    • 8.6.3.2. Regulatory framework
    • 8.6.3.3. Competitive insights
    • 8.6.3.4. Argentina Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key country dynamic
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Competitive insights
    • 8.7.2.4. South Africa Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key country dynamic
    • 8.7.3.2. Regulatory framework
    • 8.7.3.3. Competitive insights
    • 8.7.3.4. Saudi Arabia Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key country dynamic
    • 8.7.4.2. Regulatory framework
    • 8.7.4.3. Competitive insights
    • 8.7.4.4. UAE Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key country dynamic
    • 8.7.5.2. Regulatory framework
    • 8.7.5.3. Competitive insights
    • 8.7.5.4. Kuwait Intravenous (IV) Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Participant Overview
• 9.2. Company Market Position Analysis
• 9.3. Company Categorization
• 9.4. Strategy Mapping
• 9.5. Company Profiles/Listing
  • 9.5.1. Baxter International Inc.
    • 9.5.1.1. Overview
    • 9.5.1.2. Financial performance
    • 9.5.1.3. Product benchmarking
    • 9.5.1.4. Strategic initiatives
  • 9.5.2. B. Braun Melsungen AG
    • 9.5.2.1. Overview
    • 9.5.2.2. Financial performance
    • 9.5.2.3. Product benchmarking
    • 9.5.2.4. Strategic initiatives
  • 9.5.3. Otsuka Pharmaceutical Co., Ltd.
    • 9.5.3.1. Overview
    • 9.5.3.2. Financial performance
    • 9.5.3.3. Product benchmarking
    • 9.5.3.4. Strategic initiatives
  • 9.5.4. Grifols, S.A.
    • 9.5.4.1. Overview
    • 9.5.4.2. Financial performance
    • 9.5.4.3. Product benchmarking
    • 9.5.4.4. Strategic initiatives
  • 9.5.5. Vifor Pharma Management Ltd.
    • 9.5.5.1. Overview
    • 9.5.5.2. Financial performance
    • 9.5.5.3. Product benchmarking
    • 9.5.5.4. Strategic initiatives
  • 9.5.6. JW Life Science Corporation
    • 9.5.6.1. Overview
    • 9.5.6.2. Financial performance
    • 9.5.6.3. Product benchmarking
    • 9.5.6.4. Strategic initiatives
  • 9.5.7. Amanta Healthcare
    • 9.5.7.1. Overview
    • 9.5.7.2. Financial performance
    • 9.5.7.3. Product benchmarking
    • 9.5.7.4. Strategic initiatives
  • 9.5.8. NexGen Health
    • 9.5.8.1. Overview
    • 9.5.8.2. Financial performance
    • 9.5.8.3. Product benchmarking
    • 9.5.8.4. Strategic initiatives
  • 9.5.9. Core IV Therapy, LLC
    • 9.5.9.1. Overview
    • 9.5.9.2. Financial performance
    • 9.5.9.3. Product benchmarking
    • 9.5.9.4. Strategic initiatives
  • 9.5.10. Cryojuvenate UK Ltd.
    • 9.5.10.1. Overview
    • 9.5.10.2. Financial performance
    • 9.5.10.3. Product benchmarking
    • 9.5.10.4. Strategic initiatives
  • 9.5.11. REVIV
    • 9.5.11.1. Overview
    • 9.5.11.2. Financial performance
    • 9.5.11.3. Product benchmarking
    • 9.5.11.4. Strategic initiatives